Coumarin-modified androgen compounds block backdoor DHT synthesis and suppress AR-V7-positive prostate cancer cell growth.
Stable macrocyclic gadolinium chelates enable liver-specific CT and MRI imaging with high relaxivity, tolerability, and complete excretion.
Redox-activated fluorescent nanoparticles target CD206-positive TAMs to distinguish metastatic from normal lymph nodes in breast cancer imaging.
An FGE-activated sulfatase tag creates a defined antibody attachment site, avoiding heterogeneous drug loading and improving dosing consistency.
Polyfunctional dendritic carriers improve agent targeting while stabilizing nanodroplets, microbubbles, and nanoemulsions for imaging and therapy.
DOR-targeted conjugates concentrate immunotherapy and imaging in tumors, boosting immune response while lowering systemic toxicity.
Fully human CEACAM1 antibodies improve tumor selectivity and NK cell killing while reducing toxicity to normal tissues.